Andrew Jones - Ramsay Health CEO - Ramsay UK
| RMSYF Stock | USD 33.01 0.00 0.00% |
CEO
Andrew Jones is CEO - Ramsay UK of Ramsay Health Care
| Age | 49 |
| Phone | 61 2 9220 1000 |
| Web | https://www.ramsayhealth.com |
Ramsay Health Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0836 %, meaning that it generated $0.0836 on every $100 dollars invested by stockholders. Ramsay Health's management efficiency ratios could be used to measure how well Ramsay Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Ernst Wastler | Fresenius SE Co | 65 | |
| Mats Henriksson | Fresenius SE Co | 51 | |
| Andre Meyer | Life Healthcare Group | 48 | |
| Suet Lim | IHH Healthcare Berhad | 56 | |
| Prasoet Prasatthongosot | Bangkok Dusit Medical | 81 | |
| Francesco Meo | Fresenius SE Co | 60 | |
| Chatree Duangnet | Bangkok Dusit Medical | 72 | |
| Christopher Rex | Ramsay Health Care | N/A | |
| See Tan | IHH Healthcare Berhad | 52 | |
| Aziz Abdul | IHH Healthcare Berhad | 61 | |
| Joanna Szyman | Life Healthcare Group | 37 | |
| Britt Reynolds | Medical Facilities | 49 | |
| Daniel Sims | Ramsay Health Care | N/A | |
| David Chernow | Select Medical Holdings | 67 | |
| Hubert Bojdo | Life Healthcare Group | 44 | |
| Guy Blomfield | Life Healthcare Group | 48 | |
| Shrey Viranna | Life Healthcare Group | 42 | |
Management Performance
| Return On Equity | 0.0836 | |||
| Return On Asset | 0.0155 |
Ramsay Health Care Leadership Team
Elected by the shareholders, the Ramsay Health's board of directors comprises two types of representatives: Ramsay Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ramsay. The board's role is to monitor Ramsay Health's management team and ensure that shareholders' interests are well served. Ramsay Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ramsay Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Wearne, Global Chief Audit Executive | ||
| Carmel Monaghan, Group Chief of Staff | ||
| LLB BECON, Group Sec | ||
| Andrew Jones, CEO - Ramsay UK | ||
| Craig McNally, Group COO and Member of Risk Management Committee | ||
| John OGrady, Group General Counsel, Company Secretary | ||
| Patricia Akopiantz, Non-Executive Independent Director | ||
| Alison Deans, Non-Executive Director | ||
| Colleen Harris, Group Chief People Officer | ||
| Claudia Dyckerhoff, Director | ||
| Christopher Rex, CEO, Managing Director, Executive Director and Member of Risk Management Committee | ||
| John Horvath, Group Chief Medical Officer | ||
| Margaret Seale, Non-Executive Independent Director | ||
| AC DSc, Group Officer | ||
| Kah Hong, Group Care | ||
| Greg Brown, CEO Ramsay Sime Darby | ||
| Bruce Soden, Group Finance Director, Executive Director | ||
| Kelly Hibbins, Group Relations | ||
| Martyn Roberts, Group Officer | ||
| Anthony Clark, Non-Executive Independent Director | ||
| Michael Siddle, Non-Executive Chairman of the Board | ||
| Pascal Roche, CEO - Ramsay Generale De Sante | ||
| Doug Meagher, CFO Australia | ||
| David Thodey, Non-Executive Director | ||
| Peter Evans, Non-Executive Independent Deputy Chairman of the Board | ||
| Roderick McGeoch, Non-Executive Independent Director | ||
| Daniel Sims, CEO - Australian operations | ||
| Ian Grier, Non-Executive Director | ||
| Kerry Roxburgh, Non-Executive Independent Director |
Ramsay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ramsay Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0836 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 17.18 B | |||
| Shares Outstanding | 228.88 M | |||
| Shares Owned By Insiders | 21.51 % | |||
| Shares Owned By Institutions | 23.93 % | |||
| Price To Earning | 42.87 X | |||
| Price To Book | 3.96 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ramsay Health Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Ramsay Pink Sheet analysis
When running Ramsay Health's price analysis, check to measure Ramsay Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ramsay Health is operating at the current time. Most of Ramsay Health's value examination focuses on studying past and present price action to predict the probability of Ramsay Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ramsay Health's price. Additionally, you may evaluate how the addition of Ramsay Health to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |